Evidence map›Paper›PMID 23928304›Full record

ArticleThe Journal of biological chemistry2013

Autoregulation of the mechanistic target of rapamycin (mTOR) complex 2 integrity is controlled by an ATP-dependent mechanism.

Chien-Hung Chen, Vladimir Kiyan, Assylbek A Zhylkibayev, Dubek Kazyken, Olga Bulgakova, Kent E Page, Rakhmet I Bersimbaev, Eric Spooner, Dos D Sarbassov

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 34 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. NaeLife · 2017
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Chien-Hung ChenDepartment of Molecular and Cellular Oncology, University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030; University of Texas Graduate School of Biomedical Sciences, Houston, Texas 77030.
Vladimir KiyanDepartment of Molecular and Cellular Oncology, University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030; Department of Natural Sciences, L. N. Gumilyov Eurasian National University, Astana 010008, Kazakhstan.
Assylbek A ZhylkibayevDepartment of Molecular and Cellular Oncology, University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030; Department of Natural Sciences, L. N. Gumilyov Eurasian National University, Astana 010008, Kazakhstan.
Dubek KazykenDepartment of Molecular and Cellular Oncology, University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030; Department of Natural Sciences, L. N. Gumilyov Eurasian National University, Astana 010008, Kazakhstan.
Olga BulgakovaDepartment of Molecular and Cellular Oncology, University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030; Department of Natural Sciences, L. N. Gumilyov Eurasian National University, Astana 010008, Kazakhstan.
Kent E PageDepartment of Molecular and Cellular Oncology, University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030; Department of Biomedical Engineering, University of Houston, Houston, Texas 77004.
Rakhmet I BersimbaevDepartment of Natural Sciences, L. N. Gumilyov Eurasian National University, Astana 010008, Kazakhstan.
Eric SpoonerWhitehead Institute for Biomedical Research, Cambridge, Massachusetts 02142.
Dos D SarbassovDepartment of Molecular and Cellular Oncology, University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030; University of Texas Graduate School of Biomedical Sciences, Houston, Texas 77030. Electronic address: dsarbass@mdanderson.org.
L. N. Gumilyov Eurasian National University · KZThe University of Texas MD Anderson Cancer Center · USUniversity of Houston · USWhitehead Institute for Biomedical Research · US

Funding

The mTORC2 signaling in breast cancerR01CA133522 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI SARBASSOV, DOS DJURMAKHANBET · 2009 to 2013
$1.6M
NCI NIH HHS CA 133522NCI NIH HHS R01 CA133522
6 · The paper itself

Abstract

Nutrients are essential for living organisms because they fuel biological processes in cells. Cells monitor nutrient abundance and coordinate a ratio of anabolic and catabolic reactions. Mechanistic target of rapamycin (mTOR) signaling is the essential nutrient-sensing pathway that controls anabolic processes in cells. The central component of this pathway is mTOR, a highly conserved and essential protein kinase that exists in two distinct functional complexes. The nutrient-sensitive mTOR complex 1 (mTORC1) controls cell growth and cell size by phosphorylation of the regulators of protein synthesis S6K1 and 4EBP1, whereas its second complex, mTORC2, regulates cell proliferation by functioning as the regulatory kinase of Akt and other members of the AGC kinase family. The regulation of mTORC2 remains poorly characterized. Our study shows that the cellular ATP balance controls a basal kinase activity of mTORC2 that maintains the integrity of mTORC2 and phosphorylation of Akt on the turn motif Thr-450 site. We found that mTOR stabilizes SIN1 by phosphorylation of its hydrophobic and conserved Ser-260 site to maintain the integrity of mTORC2. The optimal kinase activity of mTORC2 requires a concentration of ATP above 1.2 mM and makes this kinase complex highly sensitive to ATP depletion. We found that not amino acid but glucose deprivation of cells or acute ATP depletion prevented the mTOR-dependent phosphorylation of SIN1 on Ser-260 and Akt on Thr-450. In a low glucose medium, the cells carrying a substitution of SIN1 with its phosphomimetic mutant show an increased rate of cell proliferation related to a higher abundance of mTORC2 and phosphorylation of Akt. Thus, the homeostatic ATP sensor mTOR controls the integrity of mTORC2 and phosphorylation of Akt on the turn motif site.

Indexed as

Cell ProliferationAdaptor Proteins, Signal TransducingAdenosine TriphosphateAmino Acid MotifsHeLa CellsHumansMechanistic Target of Rapamycin Complex 1Mechanistic Target of Rapamycin Complex 2Multiprotein ComplexesMutationPhosphorylationProto-Oncogene Proteins c-aktSignal TransductionTOR Serine-Threonine KinasesAdaptor Proteins, Signal TransducingAdenosine TriphosphateMAPKAP1 protein, humanMechanistic Target of Rapamycin Complex 1Mechanistic Target of Rapamycin Complex 2Multiprotein ComplexesProto-Oncogene Proteins c-aktTOR Serine-Threonine KinasesATPGlucosemTORmTOR Complex (mTORC)Protein Phosphorylation

Identifiers

PMID23928304
PMCPMC3779703
OpenAlexW2137103342

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.